FIELD: biochemistry.
SUBSTANCE: present invention relates to the field of biochemistry, namely, an antibody that binds to a feline allergen, Fel d1, compositions comprising said antibody, a nucleic acid encoding it, and a method of using said antibody. Antibodies of the present invention may also be suitable for diagnostic purposes to determine if the patient is allergic to the Fel d1 feline allergen.
EFFECT: invention makes it possible to prevent the release of histamine or other inflammatory mediators from mast cells or basophils, thus preventing or reducing the undesirable effects observed in patients sensitized to a feline allergen.
54 cl, 20 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN RET-BINDING ANTIBODIES AND METHODS OF USE THEREOF | 2020 |
|
RU2821548C2 |
| METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2014 |
|
RU2679141C2 |
| HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | 2013 |
|
RU2628305C2 |
| METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING IL-4R INHIBITOR | 2014 |
|
RU2679920C2 |
| METHODS FOR THE TREATMENT OF ALLERGY AND INCREASING THE EFFICIENCY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY BY INTRODUCING IL-4R INHIBITOR | 2014 |
|
RU2789047C2 |
| METHODS FOR PREVENTING OR TREATING ALLERGIES BY INTRODUCING AN IL-4R ANTAGONIST | 2017 |
|
RU2777328C2 |
| ANTI-ANGPTL3 ANTIBODIES AND THEIR APPLICATION | 2012 |
|
RU2620064C2 |
| ANTIBODIES AGAINST HUMAN GDF8 | 2011 |
|
RU2567805C2 |
| HUMANIZED TAU-ANTIBODY | 2013 |
|
RU2644242C2 |
| GDF8 HUMAN ANTIBODIES | 2011 |
|
RU2710156C2 |
